OSAS (obstructive sleep apnoea syndrome) therapy cuts cardiovascular events:
This article was originally published in Clinica
Executive Summary
Treating obstructive sleep apnoea syndrome (OSAS) in patients with coronary artery disease (CAD) could significantly reduce their chances of suffering from cardiovascular events. Olivier Milleron, of the Hopital Ambroise Pare, Boulogne, France, and colleagues compared the outcomes of 54 CAD patients - 25 of who received either continuous positive airway pressure therapy or surgery for OSAS, and 29 patients who were left untreated. A composite incidence of cardiovascular deaths, ischaemic events and cardiovascular hospitalisations was observed in just 24% of the treatment group versus 58% of non-treatment group, the researchers reported at the recent American College of Cardiology meeting in Chicago.